Approval · Notice of Compliance 1489 · 2003
RIVA-INDAPAMIDE: Notice of Compliance 1489
Issued February 25, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1489
- Date
- February 25, 2003
- Company
- Laboratoire Riva Inc.Blainville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Diuretic, antihypertensive agent
- Canadian reference product
- LOZIDE (Servier Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RIVA-INDAPAMIDE | 02247245 | Cancelled Post Market |
Medicinal ingredients
- INDAPAMIDE 1.25 MG per TAB